WO1996039195A3 - Oligonucleotide chimiquement modifie pour mutagenese dirigee sur site - Google Patents
Oligonucleotide chimiquement modifie pour mutagenese dirigee sur site Download PDFInfo
- Publication number
- WO1996039195A3 WO1996039195A3 PCT/US1996/008883 US9608883W WO9639195A3 WO 1996039195 A3 WO1996039195 A3 WO 1996039195A3 US 9608883 W US9608883 W US 9608883W WO 9639195 A3 WO9639195 A3 WO 9639195A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chemically modified
- site
- directed mutagenesis
- modified oligonucleotide
- molecule
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3511—Conjugate intercalating or cleaving agent
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU60432/96A AU6043296A (en) | 1995-06-06 | 1996-06-04 | Chemically modified oligonucleotide for site-directed mutage nesis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46351995A | 1995-06-06 | 1995-06-06 | |
US463,519 | 1995-06-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996039195A2 WO1996039195A2 (fr) | 1996-12-12 |
WO1996039195A3 true WO1996039195A3 (fr) | 1997-01-30 |
Family
ID=23840376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/008883 WO1996039195A2 (fr) | 1995-06-06 | 1996-06-04 | Oligonucleotide chimiquement modifie pour mutagenese dirigee sur site |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6043296A (fr) |
WO (1) | WO1996039195A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136601A (en) * | 1991-08-21 | 2000-10-24 | Epoch Pharmaceuticals, Inc. | Targeted mutagenesis in living cells using modified oligonucleotides |
US11918695B2 (en) | 2014-05-09 | 2024-03-05 | Yale University | Topical formulation of hyperbranched polymer-coated particles |
EP3139909A4 (fr) | 2014-05-09 | 2018-01-03 | Yale University | Formulation topique de particules enrobées de polyglycérol hyperramifié |
WO2017143042A2 (fr) | 2016-02-16 | 2017-08-24 | Yale University | Compositions permettant d'améliorer l'édition ciblée de gènes et leurs procédés d'utilisation |
AU2017221424A1 (en) | 2016-02-16 | 2018-09-20 | Yale University | Compositions and methods for treatment of cystic fibrosis |
WO2018187493A1 (fr) | 2017-04-04 | 2018-10-11 | Yale University | Compositions et procédés d'administration in utero |
US20210189431A1 (en) | 2018-08-10 | 2021-06-24 | Yale University | Compositions and methods for embryonic gene editing in vitro |
KR20210054547A (ko) | 2018-08-31 | 2021-05-13 | 예일 유니버시티 | 삼중체 및 뉴클레아제 기반 유전자 편집을 향상시키기 위한 조성물 및 방법 |
WO2020112195A1 (fr) | 2018-11-30 | 2020-06-04 | Yale University | Compositions, technologies et procédés d'utilisation de plérixafor pour améliorer l'édition de gènes |
US20220243211A1 (en) | 2019-06-21 | 2022-08-04 | Yale University | Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof |
US20220372474A1 (en) | 2019-06-21 | 2022-11-24 | Yale University | Hydroxymethyl-modified gamma-pna compositions and methods of use thereof |
US20220339294A1 (en) | 2019-09-09 | 2022-10-27 | Yale University | Nanoparticles for selective tissue or cellular uptake |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0253193A2 (fr) * | 1986-07-08 | 1988-01-20 | Abbott Laboratories | Méthode de mutagénèse par réparation dirigée à l'aide d'oligonucléotides d'une rupture de brin |
US5354670A (en) * | 1991-12-24 | 1994-10-11 | The President And Fellows Of Harvard College | Site-directed mutagenesis of DNA |
WO1995001364A1 (fr) * | 1993-06-25 | 1995-01-12 | Yale University | Oligonucleotide modifie chimiquement en vue d'une mutagenese dirigee vers le site |
-
1996
- 1996-06-04 AU AU60432/96A patent/AU6043296A/en not_active Abandoned
- 1996-06-04 WO PCT/US1996/008883 patent/WO1996039195A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0253193A2 (fr) * | 1986-07-08 | 1988-01-20 | Abbott Laboratories | Méthode de mutagénèse par réparation dirigée à l'aide d'oligonucléotides d'une rupture de brin |
US5354670A (en) * | 1991-12-24 | 1994-10-11 | The President And Fellows Of Harvard College | Site-directed mutagenesis of DNA |
WO1995001364A1 (fr) * | 1993-06-25 | 1995-01-12 | Yale University | Oligonucleotide modifie chimiquement en vue d'une mutagenese dirigee vers le site |
Non-Patent Citations (5)
Also Published As
Publication number | Publication date |
---|---|
WO1996039195A2 (fr) | 1996-12-12 |
AU6043296A (en) | 1996-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE161541T1 (de) | Chemische-modifizierte oligonukleotide für site- spezifisches mutagenesis | |
WO1996039195A3 (fr) | Oligonucleotide chimiquement modifie pour mutagenese dirigee sur site | |
WO1999016871A3 (fr) | Acides nucleiques catalyseurs a activite d'endonuclease | |
WO1999064582A3 (fr) | Criblage de fonction genique a haut rendement a l'aide de banques d'applications genomiques fonctionnelles | |
WO2002070755A3 (fr) | Endonucleases fen | |
ZA981762B (en) | Nucleic acid molecules encoding enzymes having fructosyl polymerase activity. | |
AU2379884A (en) | Methods and structures employing non-radioactive chemically labelled polynucleotide probes | |
EP1300466A3 (fr) | Réaction d'amplification en cascade d'acide nucléique | |
CA2188660A1 (fr) | Detection de mutations par clivage par resolvase | |
BG100188A (en) | Dna sequence enzymes | |
ATE366822T1 (de) | Verfahren zum quantitativen nachweis von nukleinsäuren | |
WO2001064898A3 (fr) | Genes codant pour des enzymes de denitrification | |
WO2003052110A3 (fr) | Acides nucleiques nematicides | |
IL96251A0 (en) | Nucleic acid probe and its use in the amplification and detection of a target gene | |
ZA853756B (en) | Nucleic acid hybridization assay employing immobilized rna probes | |
ATE202569T1 (de) | Prodrug-oligonukleotide | |
FR2723950B1 (fr) | Fragments nucleotidiques capables de s'hybrider specifiquemennt a l'adnr ou arnr des rickettsia et leur utilisation comme sondes ou amorces. | |
DE69332666T2 (de) | Verfahren zur einfachen nukleotid-primer-verlängerung zum nachweis spezifischer allele und dafür geeigneter kit | |
FR2735487B1 (fr) | Procede de transformation catalytique d'hydrocarbures en composes aromatiques avec un catalyseur contenant des metaux alcalins ou alcalino-terreux | |
WO2002090300A8 (fr) | Acides nucleiques et proteines presentant une activite de thioredoxine reductase | |
WO1994000572A3 (fr) | Gene de l'ataxie-telangiectasies du groupe de complementation d (atdc) | |
Rechnitz | Biosensors into the 1990s | |
EP0567785A3 (fr) | Protéine ayant une activité alpha-glucosidase, ADN contenant l'information génétique pour celle-ci et production d'alpha-glucosidase. | |
WO2002030266A3 (fr) | Detection d'adn endommage | |
GB2197651B (en) | Rna polymerase gene microorganism having said gene and the production of rna polymerase by the use of said microorganism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AU BB BG BR CA CN CZ EE FI GE HU IL IS JP KG KP KR LK LR LT LV MD MG MK MN MX NO NZ PL RO SG SI SK TR TT UA UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AU BB BG BR CA CN CZ EE FI GE HU IL IS JP KG KP KR LK LR LT LV MD MG MK MN MX NO NZ PL RO SG SI SK TR TT UA UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |